Tuesday, March 24, 2020, 12:00 AM - Wednesday, September 30, 2020, 12:00 AM PST

Internet Enduring Material Sponsored by Stanford University School of Medicine. Presented by the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. This 90-minute webinar will provide members of the healthcare team an overview of the various formulations of buprenorphine (including tablet, film, implantable, and injectable) for the treatment of opioid use disorder. Clinicians will learn how to manage patients with opioid use disorder and counsel them about treatment options.

Release Date: March 23, 2020
 Expiration Date: September 30, 2020
Estimated Time to Complete: 1.5 hours
CME Credits Offered: 1.50
Registration Fee: FREE

AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Participation Credit (1.50 hours)

1. Manage patients with opioid use disorder on buprenorphine and appropriately counsel them about treatment options.
2. Describe the mechanism of action of buprenorphine and determine the most effective route of administration for your patients presenting with opioid disorders.
3. Develop strategies to counsel your patients about treatment options for their opioid use disorders
4. Incorporate a team based approach to treating patients presenting with opioid use disorder.

The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The Stanford University School of Medicine designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 Credits^TM (rn.ca.gov).  Nurses will receive a Certificate of Participation following this activity that may be used for license renewal. The provider number is: 0000751.

Bibliography
Provider Resources: http://www.uclaisap.org/ca-hubandspoke/html/provider-resources.html
Factsheets and Toolkits: http://uclaisap.org/MATPrescriberSupport/html/factsheets-toolkits.html

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. 

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

For activity related questions, please contact
     Name: Laura Corbett
     Title: CME Compliance Coordinator
     Ph: 650-736-9761
     Email: laura17@stanford.edu

For CME general questions, please contact 
     Ph: (650)-497-8554
     Email: stanfordcme@stanford.edu

The registration form for this activity is currently unavailable.

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.   There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity, except: